Amanta Healthcare Ltd (AMANTA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 10039743,
    "name": "Amanta Healthcar",
    "stock_name": "Amanta Healthcar",
    "full_name": "Amanta Healthcare Ltd",
    "name_url": "stocks-analysis/amanta-healthcar",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "103.95",
    "chg": -1.1,
    "chgp": "-1.05%",
    "dir": -1,
    "prev_price": "105.05",
    "mcapval": "403.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 544502,
    "symbol": "AMANTA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE084K01015",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": "6.27 k",
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/amanta-healthcar-10039743-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Amanta Healthcare Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/amanta-healthcare-ltd-is-rated-sell-3817783",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AmantaHealthcar_mojoScore_3817783.png",
        "date": "2026-02-03 10:14:03",
        "description": "Amanta Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 03 February 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Amanta Healthcar is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/amanta-healthcar-is-rated-sell-by-marketsmojo-3801423",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AmantaHealthcar_mojoScore_3801423.png",
        "date": "2026-01-23 10:10:54",
        "description": "Amanta Healthcar is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 23 January 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Amanta Healthcar is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/amanta-healthcar-is-rated-sell-3789744",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AmantaHealthcar_mojoScore_3789744.png",
        "date": "2026-01-12 10:10:21",
        "description": "Amanta Healthcar is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Amanta Healthcar is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/amanta-healthcar-is-rated-sell-by-marketsmojo-3773041",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AmantaHealthcar_mojoScore_3773041.png",
        "date": "2025-12-29 10:10:52",
        "description": "Amanta Healthcar is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 December 2025, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Amanta Healthcare Evaluation Sees Shift Amidst Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/amanta-healthcare-downgraded-to-strong-sell-amid-weak-fundamentals-and-elevated-debt-3762065",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AmantaHealthcar_mojoScore_3762065.png",
        "date": "2025-12-18 08:25:40",
        "description": "Amanta Healthcare’s recent market assessment reflects a nuanced picture shaped by its financial performance, valuation metrics, and technical indicators. The pharmaceutical company’s long-term sales trajectory, debt servicing capacity, and return ratios have influenced a revision in its evaluation, highlighting both challenges and areas of relative strength within a competitive sector."
      },
      {
        "title": "Amanta Healthcare’s Business Fundamentals Undergo Notable Evaluation Adjustments",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/amanta-healthcare-downgraded-to-below-average-quality-amidst-weak-financial-metrics-3761849",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AmantaHealthcar_qualitydot_3761849.png",
        "date": "2025-12-18 08:00:11",
        "description": "Amanta Healthcare, a player in the Pharmaceuticals & Biotechnology sector, has experienced a shift in its business fundamentals as reflected in recent evaluation adjustments. Key financial metrics such as return on equity, return on capital employed, debt levels, and growth indicators reveal a nuanced picture of the company’s operational and financial health amid a challenging market environment."
      }
    ],
    "total": 6,
    "sid": "10039743",
    "stock_news_url": "https://www.marketsmojo.com/news/amanta-healthcare-10039743"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "06-Feb-2026",
      "details": "Intimation of schedule of the Earnings conference call for Q3 and nine months of FY 2025-26",
      "source": "BSE"
    },
    {
      "caption": "Intimation Of Opening Of Special Window For Transfer And Dematerialisation Of Physical Securities.",
      "datetime": "02-Feb-2026",
      "details": "Intimation of opening of special window for transfer and Dematerialisation of physical securities.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for To Approve Unaudited Financial Results For Quarter Ended December 31 2025.",
      "datetime": "02-Feb-2026",
      "details": "Amanta Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 inter alia to consider and approve To approve unaudited Financial Results for Quarter ended December 31 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "10 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Amanta Healthcare Ltd is Rated Sell

2026-02-03 10:14:03

Amanta Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 03 February 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Amanta Healthcar is Rated Sell by MarketsMOJO

2026-01-23 10:10:54

Amanta Healthcar is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 23 January 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Amanta Healthcar is Rated Sell

2026-01-12 10:10:21

Amanta Healthcar is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Amanta Healthcar is Rated Sell by MarketsMOJO

2025-12-29 10:10:52

Amanta Healthcar is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 December 2025, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Amanta Healthcare Evaluation Sees Shift Amidst Mixed Financial Signals

2025-12-18 08:25:40

Amanta Healthcare’s recent market assessment reflects a nuanced picture shaped by its financial performance, valuation metrics, and technical indicators. The pharmaceutical company’s long-term sales trajectory, debt servicing capacity, and return ratios have influenced a revision in its evaluation, highlighting both challenges and areas of relative strength within a competitive sector.

Read full news article

Amanta Healthcare’s Business Fundamentals Undergo Notable Evaluation Adjustments

2025-12-18 08:00:11

Amanta Healthcare, a player in the Pharmaceuticals & Biotechnology sector, has experienced a shift in its business fundamentals as reflected in recent evaluation adjustments. Key financial metrics such as return on equity, return on capital employed, debt levels, and growth indicators reveal a nuanced picture of the company’s operational and financial health amid a challenging market environment.

Read full news article

View All News